|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | |
| A61K 31/137 | |||
| A61K 31/485 | |||
| A61K 47/18 | |||
| A61K 47/26 | |||
| A61P 25/30 | |||
| A61P 25/36 |
| (11) | Patento numeris | 2379111 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09831343.0 |
| Europos patento paraiškos padavimo data | 2009-12-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-10-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-03-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CA2009/001778 |
| Data | 2009-12-14 |
| (87) | Numeris | WO 2010/066034 |
| Data | 2010-06-17 |
| (30) | Numeris | Data | Šalis |
| 122117 P | 2008-12-12 | US |
| (72) |
VINSON, Robert, CA
GOSSELIN, Patrick, CA
BETANCOURT, Aimesther, Ojito, CA
|
| (73) |
Paladin Labs Inc.,
6111 Royalmount Avenue, Suite 102, Montreal, QC H4P 2T4,
CA
|
| (54) | NARCOTIC DRUG FORMULATIONS WITH DECREASED ABUSE POTENTIAL |
| NARCOTIC DRUG FORMULATIONS WITH DECREASED ABUSE POTENTIAL |